Literature DB >> 7504231

Transformation of chicken bone marrow cells by the v-ski oncogene.

J Larsen1, S Meyer, P Steinlein, H Beug, M J Hayman.   

Abstract

The effect of the v-ski oncogene on the transformation of chicken hematopoietic cells was examined. In initial experiments viruses encoding the v-ski oncoprotein did not transform chicken bone marrow cells. However, whereas viruses encoding the ts-v-sea oncoprotein transform solely erythroid cells, viruses encoding both the v-ski and the ts-v-sea oncogenes were found capable of transforming myeloid cells from the monocytic and/or granulocytic lineages in addition to erythroid cells. Analysis of cell clones transformed by the v-ski/ts-v-sea virus identified one clone that no longer expressed the v-sea protein, indicating that this protein was necessary for the initiation but not the maintenance of transformation. Subsequent experiments testing the effects of various growth factors on transformation of bone marrow cells by the v-ski oncogene product alone identified the avian c-kit ligand (stem cell factor; SCF) as being able to co-operate with the v-ski protein to cause transformation of chicken hematopoietic cells of both myeloid and erythroid lineages.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504231

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Ski can negatively regulates macrophage differentiation through its interaction with PU.1.

Authors:  N Ueki; L Zhang; M J Hayman; M J Haymann
Journal:  Oncogene       Date:  2007-07-09       Impact factor: 9.867

2.  Ski protein levels increase during in vitro progression of HPV16-immortalized human keratinocytes and in cervical cancer.

Authors:  Yi Chen; Lucia Pirisi; Kim E Creek
Journal:  Virology       Date:  2013-06-27       Impact factor: 3.616

Review 3.  Vectors derived from avian leukosis and sarcoma viruses.

Authors:  F Flamant; F L Cosset; J Samarut
Journal:  J Mol Med (Berl)       Date:  1995-04       Impact factor: 4.599

4.  DNA binding and transcriptional activation by the Ski oncoprotein mediated by interaction with NFI.

Authors:  P Tarapore; C Richmond; G Zheng; S B Cohen; B Kelder; J Kopchick; U Kruse; A E Sippel; C Colmenares; E Stavnezer
Journal:  Nucleic Acids Res       Date:  1997-10-01       Impact factor: 16.971

5.  The sno gene, which encodes a component of the histone deacetylase complex, acts as a tumor suppressor in mice.

Authors:  T Shinagawa; H D Dong; M Xu; T Maekawa; S Ishii
Journal:  EMBO J       Date:  2000-05-15       Impact factor: 11.598

6.  Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial, patterning, and skeletal muscle development.

Authors:  M Berk; S Y Desai; H C Heyman; C Colmenares
Journal:  Genes Dev       Date:  1997-08-15       Impact factor: 11.361

7.  MLL-ENL cooperates with SCF to transform primary avian multipotent cells.

Authors:  Cathleen E Schulte; Marieke von Lindern; Peter Steinlein; Hartmut Beug; Leanne M Wiedemann
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

8.  Ski negatively regulates erythroid differentiation through its interaction with GATA1.

Authors:  Nobuhide Ueki; Leiqing Zhang; Michael J Hayman
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

9.  Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.

Authors:  Alexandre Fagnan; Frederik Otzen Bagger; Maria-Riera Piqué-Borràs; Cathy Ignacimouttou; Alexis Caulier; Cécile K Lopez; Elie Robert; Benjamin Uzan; Véronique Gelsi-Boyer; Zakia Aid; Cécile Thirant; Ute Moll; Samantha Tauchmann; Amina Kurtovic-Kozaric; Jaroslaw Maciejewski; Christine Dierks; Orietta Spinelli; Silvia Salmoiraghi; Thomas Pabst; Kazuya Shimoda; Virginie Deleuze; Hélène Lapillonne; Connor Sweeney; Véronique De Mas; Betty Leite; Zahra Kadri; Sébastien Malinge; Stéphane de Botton; Jean-Baptiste Micol; Benjamin Kile; Catherine L Carmichael; Ilaria Iacobucci; Charles G Mullighan; Martin Carroll; Peter Valent; Olivier A Bernard; Eric Delabesse; Paresh Vyas; Daniel Birnbaum; Eduardo Anguita; Loïc Garçon; Eric Soler; Juerg Schwaller; Thomas Mercher
Journal:  Blood       Date:  2020-08-06       Impact factor: 25.476

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.